CMND
Clearmind Medicine Inc. - Common Shares (CMND)
$07
About Clearmind Medicine Inc. - Common Shares (CMND)
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
$0.08
Daily low
$0.07
Price at open
$0.08
52 Week High
$2.18
52 Week Low
$0.07
Market cap
235,500
Dividend yield
0.00%
Volume
3.0M
Avg. volume
23.7M
P/E ratio
-.09
Clearmind Medicine Inc. - Common Shares News
Details
Daily high
$0.08
Daily low
$0.07
Price at open
$0.08
52 Week High
$2.18
52 Week Low
$0.07
Market cap
235,500
Dividend yield
0.00%
Volume
3.0M
Avg. volume
23.7M
P/E ratio
-.09